ZA200110271B - Substituted 3-pyridyl-4-arylpyrroles, and related therapeutic and prophylatic methods. - Google Patents

Substituted 3-pyridyl-4-arylpyrroles, and related therapeutic and prophylatic methods.

Info

Publication number: ZA200110271B
Authority: ZA; South Africa
Prior art keywords: arylpyrroles; prophylatic; pyridyl; substituted; methods
Prior art date: 1999-05-14

Application number

ZA200110271A

Other languages

English (en)

Inventor

James Bullington

Original Assignee

Orthomcneil Pharmaceutical Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-05-14

Filing date

2001-12-13

Publication date

2003-05-28

2001-12-13 Application filed by Orthomcneil Pharmaceutical Inc filed Critical Orthomcneil Pharmaceutical Inc

2003-05-28 Publication of ZA200110271B publication Critical patent/ZA200110271B/xx

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond

ZA200110271A 1999-05-14 2001-12-13 Substituted 3-pyridyl-4-arylpyrroles, and related therapeutic and prophylatic methods. ZA200110271B (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US13413999P	1999-05-14	1999-05-14

Publications (1)

Publication Number	Publication Date
ZA200110271B true ZA200110271B (en)	2003-05-28

Family

ID=22461942

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
ZA200110271A ZA200110271B (en)	1999-05-14	2001-12-13	Substituted 3-pyridyl-4-arylpyrroles, and related therapeutic and prophylatic methods.

Country Status (23)

Country	Link
US (1)	US6562843B1 (xx)
EP (1)	EP1178981B1 (xx)
JP (1)	JP2002544272A (xx)
KR (1)	KR20010114267A (xx)
CN (1)	CN1210273C (xx)
AR (1)	AR023986A1 (xx)
AT (1)	ATE243690T1 (xx)
AU (1)	AU777702B2 (xx)
BR (1)	BR0010560A (xx)
CA (1)	CA2374559A1 (xx)
DE (1)	DE60003550T2 (xx)
DK (1)	DK1178981T3 (xx)
ES (1)	ES2200878T3 (xx)
HK (1)	HK1042901B (xx)
IL (1)	IL146465A0 (xx)
MX (1)	MXPA01011720A (xx)
MY (1)	MY127675A (xx)
NZ (1)	NZ515531A (xx)
PT (1)	PT1178981E (xx)
RU (1)	RU2238940C2 (xx)
TW (1)	TWI229671B (xx)
WO (1)	WO2000069847A1 (xx)
ZA (1)	ZA200110271B (xx)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7122666B2 (en)	1999-07-21	2006-10-17	Sankyo Company, Limited	Heteroaryl-substituted pyrrole derivatives, their preparation and their therapeutic uses
GB0102672D0 (en) *	2001-02-02	2001-03-21	Glaxo Group Ltd	Compounds
US7446106B2 (en) *	2001-09-05	2008-11-04	Smithkline Beecham Plc	Pyridylfurans and pyrroles as Raf kinase inhibitors
BR0314783A (pt) *	2002-09-27	2005-07-26	Janssen Pharmaceutica Nv	Pirróis 3,4-dissubstituìdos e seu uso no tratamento de doenças inflamatórias
JP4808154B2 (ja) *	2003-03-13	2011-11-02	バーテックスファーマシューティカルズインコーポレイテッド	プロテインキナーゼインヒビターとして有用な組成物
DE602004029355D1 (de) *	2003-05-26	2010-11-11	Takeda Pharmaceutical	Sulfopyrrolderivate
JP2006527197A (ja) *	2003-06-06	2006-11-30	ザ・トラスティーズ・オブ・ザ・ユニバーシティ・オブ・ペンシルバニア	ｐ３８キナーゼ阻害剤組成物及びその使用方法
US7531560B2 (en) *	2004-11-10	2009-05-12	Boehringer Ingelheim Pharmaceuticals, Inc.	Anti-cytokine heterocyclic compounds
US8033692B2 (en) *	2006-05-23	2011-10-11	Cree, Inc.	Lighting device

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3994890A (en)	1974-01-31	1976-11-30	Chugai Seiyaku Kabushiki Kaisha	1-Aminoalkyl, 3-phenyl indazoles
JPH0615542B2 (ja)	1986-07-22	1994-03-02	吉富製薬株式会社	ピラゾロピリジン化合物
IL104369A0 (en)	1992-01-13	1993-05-13	Smithkline Beecham Corp	Novel compounds and compositions
WO1997005878A1 (en)	1995-08-10	1997-02-20	Merck & Co., Inc.	2,5-substituted aryl pyrroles, compositions containing such compounds and methods of use
AU705082B2 (en) *	1995-08-10	1999-05-13	Merck & Co., Inc.	2-substituted aryl pyrroles, compositions containing such compounds and methods of use
AU702887B2 (en)	1995-10-31	1999-03-11	Merck & Co., Inc.	Substituted pyridyl pyrroles, compositions containing such compounds and methods of use
BR9710352A (pt) *	1996-07-11	1999-08-17	Pfizer	Compostos piridilpirrole
US5776954A (en)	1996-10-30	1998-07-07	Merck & Co., Inc.	Substituted pyridyl pyrroles, compositions containing such compounds and methods of use

2000
- 2000-04-28 CN CNB008103291A patent/CN1210273C/zh not_active Expired - Fee Related
- 2000-04-28 AU AU46777/00A patent/AU777702B2/en not_active Ceased
- 2000-04-28 ES ES00928559T patent/ES2200878T3/es not_active Expired - Lifetime
- 2000-04-28 CA CA002374559A patent/CA2374559A1/en not_active Abandoned
- 2000-04-28 US US09/561,534 patent/US6562843B1/en not_active Expired - Lifetime
- 2000-04-28 JP JP2000618264A patent/JP2002544272A/ja active Pending
- 2000-04-28 RU RU2001133452A patent/RU2238940C2/ru not_active IP Right Cessation
- 2000-04-28 EP EP00928559A patent/EP1178981B1/en not_active Expired - Lifetime
- 2000-04-28 BR BR0010560-0A patent/BR0010560A/pt not_active Application Discontinuation
- 2000-04-28 IL IL14646500A patent/IL146465A0/xx unknown
- 2000-04-28 DE DE60003550T patent/DE60003550T2/de not_active Expired - Fee Related
- 2000-04-28 KR KR1020017014523A patent/KR20010114267A/ko not_active Application Discontinuation
- 2000-04-28 AT AT00928559T patent/ATE243690T1/de not_active IP Right Cessation
- 2000-04-28 MX MXPA01011720A patent/MXPA01011720A/es active IP Right Grant
- 2000-04-28 DK DK00928559T patent/DK1178981T3/da active
- 2000-04-28 PT PT00928559T patent/PT1178981E/pt unknown
- 2000-04-28 WO PCT/US2000/011531 patent/WO2000069847A1/en active IP Right Grant
- 2000-04-28 NZ NZ515531A patent/NZ515531A/xx unknown
- 2000-05-15 AR ARP000102325A patent/AR023986A1/es unknown
- 2000-05-15 MY MYPI20002126A patent/MY127675A/en unknown
- 2000-08-18 TW TW089109388A patent/TWI229671B/zh not_active IP Right Cessation
2001
- 2001-12-13 ZA ZA200110271A patent/ZA200110271B/xx unknown
2002
- 2002-06-20 HK HK02104618.2A patent/HK1042901B/zh not_active IP Right Cessation

Also Published As

Publication number	Publication date
IL146465A0 (en)	2002-07-25
EP1178981A1 (en)	2002-02-13
PT1178981E (pt)	2003-11-28
AU777702B2 (en)	2004-10-28
CN1210273C (zh)	2005-07-13
BR0010560A (pt)	2002-06-04
AR023986A1 (es)	2002-09-04
TWI229671B (en)	2005-03-21
DE60003550T2 (de)	2004-04-15
MY127675A (en)	2006-12-29
HK1042901B (zh)	2003-11-07
JP2002544272A (ja)	2002-12-24
RU2238940C2 (ru)	2004-10-27
DK1178981T3 (da)	2003-09-29
ATE243690T1 (de)	2003-07-15
AU4677700A (en)	2000-12-05
KR20010114267A (ko)	2001-12-31
NZ515531A (en)	2004-03-26
HK1042901A1 (en)	2002-08-30
WO2000069847A1 (en)	2000-11-23
MXPA01011720A (es)	2003-10-14
US6562843B1 (en)	2003-05-13
EP1178981B1 (en)	2003-06-25
DE60003550D1 (de)	2003-07-31
ES2200878T3 (es)	2004-03-16
CN1361773A (zh)	2002-07-31
CA2374559A1 (en)	2000-11-23

Publication	Publication Date	Title
ZA200201806B (en)	2003-05-28	Substituted 2-thio-3,5-dicyano-4-aryl-6-aminopyridines and the use thereof.
MXPA01012635A (es)	2003-09-04	Dispositivos, sistemas y metodos para auxiliar al corazon.
ZA200107983B (en)	2002-05-29	New compounds, their preparation and use.
PL355109A1 (en)	2004-04-05	Tert.
MXPA02001896A (es)	2003-07-21	Placa de apertura mejorada y metodos para su construccion y uso.
HK1047743A1 (en)	2003-03-07	New use and novel n-azabicyclo-amide derivatives.
HK1061679A1 (en)	2004-09-30	Phenylsulfonyl-1,3-dihydro-2h-indole-2-ibe derivatives, their preparation and their therapeutic use.
MXPA01013362A (es)	2003-09-04	Anticuerpos de humano, anti-alfavbeta3 recombinantes, °cidos nucleicos que codifican a los mismos y metodos de uso.
ZA200104196B (en)	2002-07-25	Azepinoindole derivatives, the production and use thereof.
MXPA02006460A (es)	2003-09-22	Trifluorometilpirrolcarboxamidas y trifluorometilpirroltioamidas como fungicidas.
HK1054384A1 (en)	2003-11-28	4-Pyrimidinyl-n-acyl-l-phenylalanines.
HK1053470A1 (en)	2003-10-24	4-Pyridinyln-acyl-l-phenylalanines.
ZA200001746B (en)	2000-12-06	3-amino-3-arylpropan-1-ol derivatives, and their preparation and use.
EP1210084A4 (en)	2002-11-13	PYRIDOMORPHINANS, THIENOMORPHINANS AND THEIR USE
HK1046792A1 (en)	2003-01-24	Transmitting device and method.
ZA200110271B (en)	2003-05-28	Substituted 3-pyridyl-4-arylpyrroles, and related therapeutic and prophylatic methods.
MXPA03006249A (es)	2003-09-22	Derivados de 2-arilimino-2,3-dihidrotiazoles, sus procesos de preparacion y su uso terapeutico.
ZA200007111B (en)	2001-06-05	Methods and devices for providing prolonged drug therapy.
ZA200110046B (en)	2003-03-06	Therapeutic agents.
GB0029720D0 (en)	2001-01-17	I.S machine7544232001
MXPA03006162A (es)	2003-09-16	Derivados de mikanolida, su preparacion y sus usos terapeuticos.
ZA200001747B (en)	2000-10-26	3-Amino-3-arylpropan-1-ol derivatives, their preparation and use.
ZA200109571B (en)	2002-11-20	Novel compounds, their use and preparation.
IL161859A0 (en)	2005-11-20	3-Heteroaryl-3.5-dihydro-4-oxo-4H-pyridazinoÄ4.5-BÜindole-1-carboxamide derivatives, their preparation and therapeutic use
GB9903539D0 (en)	1999-04-07	Therapy using M.Vaccae